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Abstract
Background: Appropriate nutrition during early development is essential for maximal bone mass accretion; however,
linkage between early nutrition, childhood bone mass, peak bone mass in adulthood, and prevention of bone loss later in
life has not been studied.
Methodology and Principal Findings: In this report, we show that feeding a high quality diet supplemented with
blueberries (BB) to pre-pubertal rats throughout development or only between postnatal day 20 (PND20) and PND34
prevented ovariectomy (OVX)-induced bone loss in adult life. This protective effect of BB is due to suppression of
osteoblastic cell senescence associated with acute loss of myosin expression after OVX. Early exposure of pre-osteoblasts to
serum from BB-fed rats was found to consistently increase myosin expression. This led to maintenance osteoblastic cell
development and differentiation and delay of cellular entrance into senescence through regulation of the Runx2 gene. High
bone turnover after OVX results in insufficient collagenous matrix support for new osteoblasts and their precursors to
express myosin and other cytoskeletal elements required for osteoblast activity and differentiation.
Conclusions/Significance: These results indicate: 1) a significant prevention of OVX-induced bone loss from adult rats can
occur with only 14 days consumption of a BB-containing diet immediately prior to puberty; and 2) the molecular
mechanisms underlying these effects involves increased myosin production which stimulates osteoblast differentiation and
reduces mesenchymal stromal cell senescence.
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Introduction
The development of degenerative bone disorders, such as
osteoporosis, is associated with genetics and gene-environment
interactions. Such disorders begin early in life but the complete
phenotypic presentation can take decades to be manifested [1].
Hormone replacement therapy and medications have been the
treatment of choice for conditions characterized by bone loss (such
as postmenopausal osteoporosis) [2]. However, the extent to which
these treatments can solve long-term problems of bone loss and
resultant fragility is questionable. Attaining greater peak bone
mass during critical bone-forming years could potentially delay the
decline of bone mass to such an extent as to prevent or greatly
delay the onset of osteoporosis [3], thus making the need for
treatment either less likely or shorter, and significantly reducing
health care costs. The majority of bone mass acquisition occurs
between the ages of 12 and 18 years and results from substantial
osteoblastic bone formation under control of an array of genes
which interact with endogenous hormones and environmental
factors [4].
In the search for alternative management of osteoporosis,
potential preventive strategies through lifestyle changes involving
diet and physical activity have recently received increased
attention. For example, population-based studies indicate that
fruit and vegetable intake are independent predictors of bone size
in early pubertal children [5], [6]. Blueberries have recently been
shown to promote osteoblastic bone formation without affecting
normal growth in rapidly growing rodents, and this bone-
promoting effect appears to be due to stimulation of osteoblastic
differentiation caused by phenolic acid metabolites derived from
BB polyphenols [7].
In general, bone formation is dependent on the activity and
differentiation of osteoblasts; whereas, resorption of preexisting
mineralized bone matrix by osteoclasts is necessary for bone
remodeling [8]. In young rapidly growing animals, bone formation
usually exceeds bone resorption resulting in bone accrual. Bone
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potential sources of new osteoblasts [9]. Contact with bone
collagenous matrix provides an important regulatory factor for
these cells to function and differentiate [10]. Indeed, differentia-
tion of mesenchymal stem cells toward tissue specific lineages is
extremely sensitive to matrix qualities, such as elasticity [11]. It is
still unclear whether accelerated degradation of collagens in bone
matrix resulting from sex steroid deficiency results in secondary
effects on osteoblast differentiation. In addition, cytoskeletal
organization of mesenchymal stromal cells [12] or osteoblast
precursors is thought to be critical for their differentiation into
mature, functioning osteoblasts. To date, the relationship between
sex steroid deficiency, cytoskeletal organization, bone and
osteoblastic cell senescence is not well defined. Based upon our
previous studies, we hypothesized dietary factors might affect bone
matrix properties and organization of bone cell cytoskeleton, and
thus prevent bone loss due to accumulation of senescent and
dysfunctional osteoblasts or osteoblastic precursors which occurs
under conditions of sex steroid deficiency.
Here we report that ovariectomy (OVX) triggers osteoblastic
cell senescence in bone tissue along with decreased expression of
myofibril genes. We have found that a diet containing BB prevents
OVX-induced osteoblastic cell senescence and bone loss in adult
female rats. We have shown that this protective effect requires only
a very short period of time (between postnatal days 20 and 33) to
be effective well into adulthood. We have demonstrated that early
exposure of osteoblastic cells or mesenchymal stromal cells to BB
diet maintains long-term cytoskeletal stability through regulation
of myosin and Runx2 genes. Furthermore, we have identified
molecular events of mesenchymal stromal cell senescence and
osteoblast differentiation associated with OVX.
Results
Pre-pubertal consumption of a BB-containing diet
prevents adult bone loss
We have previously reported that feeding a diet supplemented
with BB to rats throughout life significantly promoted osteoblastic
bone formation in rapidly growing male and female rats [7]. In the
current study, in addition to long term BB feeding, additional
groups of rats were weaned to the BB-containing diet starting on
postnatal day 20 (PND20) and ending on PND34. They were fed a
non-BB-containing control diet thereafter. This is referred to as
short-term BB group. Our intent was to determine if a brief period
of BB exposure early in the life of these rats would prevent bone
loss when they were adults. Their bone parameters were compared
to groups fed the control or BB-containing diets from PND20 until
sacrifice. On PND60, all rats were ovariectomized and sacrificed 1
or 3 weeks later (see Figure S1 for experimental design). There
were no significant differences in weight gain between comparable
groups (Figure S1). After one or three weeks, OVX rats had
decreased bone mass, including reduction in bone mineral density
(BMD), and bone mineral content (BMC) compared with sham-
operated animals (p,0.05) (Figure 1). Short-term feeding the BB-
containing diet from PND20 to PND34 significantly blocked
OVX-induced bone loss; whereas, long-term BB feeding increased
bone mass compared to sham controls (Figure 1). Histomorpho-
metric analysis of long bone sections indicated that the growth
plates were not significantly altered by diet. Compared to sham-
operated controls, BB-fed rats had increased (p,0.05) osteoblastic
indices: including, trabecular bone volume; trabecular number;
osteoblast numbers; and bone formation without significant
changes in osteoclast parameters (Figure 2). After 3 weeks OVX,
adult rats fed the BB diet from PND21 to PND34 had higher
(p,0.05) levels of trabecular bone volume, osteoblast number and
bone formation rate, but lower (p,0.05) numbers of osteoclasts
compared to sham-operated or OVX controls (Figure 2).
Consistent with the results on bone mass and histomorphomet-
ric data, we found that one week after OVX, the bone formation
marker osteocalcin and the bone resporption marker RatLaps
were increased (p,0.05) in control diet-fed OVX rats compared
with their sham controls (Table 1). Surprisingly, alkaline
phophatase (ALP), was lower (p,0.05) in OVX animals compared
to their sham control (Table 1). Osteocalcin remained higher in
BB-fed groups compared to either sham or OVX control groups
three weeks following OVX; whereas, ALP in BB-fed groups was
equal to sham, but higher than the OVX control. In contrast,
RatLaps was lower in BB-fed groups compared to control OVX
controls, but higher than the sham operated controls (Table 1). It
should to be noted that some of the effects of BB diet on bone in
OVX rats are similar to previously published effects of estrogen
replacement. However, the serum estradiol concentrations did not
differ among OVX groups (data not shown). Importantly, these
results indicate persistent bone formation effects associated with
consumption of a BB-containing diet for a short period in early
development. These data are clearly distinct from the effects of
either anabolic or anti-remodeling agents reported previously [13]
and suggest that adult peak bone mass may be enhanced by
dietary intervention early in life.
Myosin in bone is a target for prevention of OVX-induced
bone loss by BB
During early life, substantial bone formation is regulated by an
array of genes which interact with endogenous hormones and
environmental factors [14]. In an effort to determine which target
genes are interacting with dietary factors in BB to protect against
OVX-induced bone loss, mRNA from long bone of rats sacrificed
3 weeks post-OVX was studied using Affymetrix gene arrays.
These analyses revealed a cluster of genes containing cell
cytoskeletal motor proteins, particularly myosin, that was down-
regulated in bone in the OVX control group compared with the
sham-operated group (Figure 3A); whereas, another cluster of
genes related to collagen turnover was up-regulated (Figure 3B).
These data suggest a compensatory response to high bone
turnover and bone formation after OVX. Feeding BB diets,
particularly the short-term early in life, inhibited OVX-induced
down-regulation of myosin-related genes (p,0.05), although BB
did not completely block the OVX effect on myosin expression.
For example, myosin 4 and 7 were down-regulated 400-fold in the
control diet-fed OVX group compared with their sham-operated
animals, and BB diet prevented more than 75% of this reduction.
In contrast, the BB diet did not inhibit OVX-induced up-
regulation of genes related to collagen synthesis, but rather
enhanced expression of these genes above that seen OVX controls
(Figure 3B). This suggests that BB promoted osteoblast differen-
tiation or increased osteoblast activity. Real-time RT-PCR
confirmed that gene expression of three subtypes of myosin, i.e.
2, 4 and 7, known as nonmuscular myosins, were profoundly
reduced in the OVX controls. Furthermore, using real-time RT-
PCR, we found that Runx2 expression was lower, osteocalcin
expression was higher, and ALP expression was unchanged in
samples from the OVX control group compared with their sham-
operated control (p,0.05; Figure 3C). All three genes were
increased (p,0.05) in OVX animals fed BB diets compared with
sham-operated controls (Figure 3C). Myosin and Runx2 protein
expression patterns were confirmed using Western blotting
(Figure 3D). These results prompted us to explore the true
significance of inhibition of OVX-induced down-regulation of
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galactosidase (SABG) activity, a biomarker and one of phenotypes
of senescent tissues or cells [15] was examined from total protein
isolated from bone. It was increased (p,0.05) one and three weeks
following OVX compared with sham-operated controls
(Figure 4A). SABG activity in BB-fed rats one week post-OVX
approximated levels in sham-operated controls (Figure 4A). SABG
activity three weeks after OVX in animals fed BB diet long-term
was lower (p,0.05) than sham-operated controls, while rats fed
the BB diet of short-term early in development did not differ from
the sham-operated control group (Figure 4A). These results are
reflected in the bone mass data presented in Figure 1.
We next examined whether there are associations between
osteoblast senescence, myosin and Runx2 expression in bone three
weeks after OVX with or without BB diet using triple staining of
SABG activity staining, myosin and Runx2 immunostaining. We
found that osteoblasts on the surface of bone from OVX animals
showed relatively more staining of blue for SABG, less myosin and
Runx2 staining, and were flattened and increased in size
compared with those from sham-operated animals (Figure 4B).
Cells from OVX animals fed the BB diet either for a short-term
early in life or over a long-term showed no obvious differences
compared with sham-operated controls (Figure 4B) (Figure S2).
Serum from BB diet-fed rats induced osteoblastic cell
commitment and differentiation involving myosin
We believe tissue-specific dietary effects are mediated by
bioactive compounds derived from the BB diet that appear in
the peripheral circulation following digestion. Serum from rats fed
the BB diet (BB serum) was used to treat osteogenic and osteoblast
progenitor cells in vitro to test our hypothesis. To obtain
pretreatment measures, we first determined myosin expression in
Figure 1. Continuous and early life short term blueberry diet prevents bone loss in adults. Parameters from pQCT analysis. Five
consecutive slices from each rat tibia were scanned in a blinded manner. Data were analyzed from slices 3 and 4 (average). OVX, Ovariectomy; BMD,
Bone mineral density; LTBB OVX, long term blueberry supplemented diet throughout experiment and ovariectomy. STBB OVX, short term blueberry
diet for 14 days from weaning postnatal date 20 to PND 34, then switch to control diet and ovariectomy. Data are expressed as mean 6 SEM (n=8
per group). Significant differences indicated by p,0.05, a,b,c.
doi:10.1371/journal.pone.0024486.g001
Effects of Blueberry Diet on Bone Loss
PLoS ONE | www.plosone.org 3 September 2011 | Volume 6 | Issue 9 | e24486osteogenic rat fetal calvarial cells and mouse-derived bone marrow
mesenchymal stromal ST2 cells. Based on previous microarray
analysis (presented in Figure 3), myosin 1–4, 6 and 7 were
profoundly down-regulated in bone from OVX controls. We then
checked these 6 subtypes of myosin expression in pure osteoblastic
cells using regular PCR and found they were all highly expressed
in calvarial cells relative to their expression in ST2 cells
(Figure 5A). ST2 cells (and data from calvarial cells were presented
in Figure S3) were then treated with 2% rat serum from either
control or 14 d BB diet-fed female rats sacrificed on PND34.
Treatment of ST2 cells with BB serum for 72 h increased (p,0.05)
gene expression of the transcription factor Runx2 and increased
(p,0.05) all myosin subtype gene expressions (Figure 5B).
Consistent with in vivo bone mass data, we found that after
treatment of ST2 cells with BB serum for three days and return to
regular cell culture medium for additional 4 days, ALP gene
expression remained significantly higher than those in cells treated
with serum from control diet-fed rats (Figure 5C). These data
indicate that BB serum is able to induce mesenchymal stromal cell
commitment to osteoblastic cell lineage. Using Affymetrix gene
Figure 2. Static and dynamic histomorphometric parameters after OVX in female rats. Proximal tibia sections were histologically stained
with Von Kossa and pictures were represented one from each group, and under Von Kossa staining, pictures were showing bone calcein double
labeling. * p,0.05, versus Sham as determined by t-test. OVX; ovariectomy. LTBB; long-term blueberry. STBB; Short term blueberry.
doi:10.1371/journal.pone.0024486.g002
Table 1. Serum bone turnover markers after OVX in female rats.
1 week after OVX
Sham OVX LTBB OVX STBB OVX
Osteocalcin (ng/ml) 397.5658.8
a 485.2647.2
b 450.2619.8
b 453.0635.6
b
ALP (mU/min) 1.1660.13
c 0.8060.14
a 1.0760.14
b 1.0660.18
b
RatLaps (ng/ml) 19.161.9
a 27.462.2
c 20.463.8
a,b 23.160.8
b
3 weeks after OVX
Sham OVX LTBB OVX STBB OVX
Osteocalcin (ng/ml) 377.5630.5
a 377.1647.2
a 433.3638.8
b 425.0620.8
b
ALP (mU/min) 1.0060.18
b 0.8160.17
a 1.0860.21
c 1.0160.20
b
RatLaps (ng/ml) 15.561.1
a 26.561.6
c 21.161.6
b 22.262.1
b
P,0.05, a,b,c as determined by one way ANOVA followed by Student-Newman-Keuls post hoc analysis for multiple pairwise comparisons. OVX; ovariectomy. LTBB;
long-term blueberry. STBB; Short term blueberry.
doi:10.1371/journal.pone.0024486.t001
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early commitment markers through mid/late development
markers, were consistent with results from real-time PCR analysis
(Figure S4). Surprisingly, in the presence of blebbistatin, a non-
muscle myosin 2 specific inhibitor, the osteogenic effects of BB
serum was blocked (Figure 5D). These data suggest that myosin, or
at least non-muscular myosin, is involved in BB diet-induced
osteoblast commitment or differentiation.
Osteoblastic cell shape maintenance and senescence
prevention by dietary BB through myosin and Runx2
We have shown above that BB diet short-term in early life
protected against OVX-induced bone loss in adults, and that this
effect may be due to the ability of dietary BB to suppress OVX-
induced osteoblast senescence associated with reduced myosin
expression. To further confirm this and in vivo data, we utilized
fetal calvarial cells (and ST2 cells as data presented in Figure S5).
Cells were treated for 3 days with 2% rat serum taken from adult
female sham-operated or OVX (3 weeks post-OVX) rats fed non-
BB-containing diets. Similar groups of cells were treated with
serum from adult female rats fed long-term the BB diet from
weaning and sacrificed 3 weeks following OVX. After three days
of serum treatment, all cells were then cultured in normal medium
and cell cultures were continued in the presence of regular cell
culture medium for nine passages (Figure S6A). We identified the
total population of cells that were confluent every 5d to 6d. We
found that cells cultured in control medium or exposed to serum
from sham-operated or OVX controls for three days at the
beginning of the experiment gradually and significantly descended
in number, particularly after passage four (Figure S6B). In
contrast, even after four passages, cells exposed to rat serum from
BB-fed OVX rats, had numbers which remained relatively similar
to their previous passage (Figure S6B). Although, after nine
passages, fetal calvarial cells were still able to proliferate and did
not reach crisis, cells treated with serum from control diet-fed
OVX rats had higher (p,0.05) SABG activity (Figure 6A) and
more SABG-stained, morphologically-altered cells (Figure 6B)
compared with the other three treatments. mRNA and protein
were isolated from cells after 9 passages following all 4 treatments.
Gene expression of the osteoblast differentiation markers ALP and
Runx2 were higher (p,0.05) in cells pretreated with serum from
OVX BB diet-fed rats compared to those cells pretreated with
serum from OVX control rats (Figure 6C). This was accompanied
by higher (p,0.05) gene expression of myosin (Figure 6C).
Moreover, we have observed consistent and significant differences
of Runx2 and myosin gene encoded protein expression using
Western blot analyses (Figure 6D). As in our previous in vivo
analysis, myosin and Runx2 double immuno-staining was
performed on passage nine cells that had been subjected different
serum treatments for only three days at beginning of the
experiment. We found that expression of Runx2 was lower
(p,0.05) in cells from OVX control diet rat serum treatment
compared with the other treatments (Figure 6E). Clearly,
decreased expression of Runx2 in cells treated with serum from
OVX control rats was accompanied by lower (p,0.05) expression
of myosin (Figure 6E). Interestingly, SABG-stained positive cells
Figure 3. Myosin is the target gene for dietary BB effects on bone in OVX animals. Microarray profiling of bone cell transcripts in RNA from
bone with or without BB and OVX. (A), Cluster of myosin related genes and, (B), cluster of collagen turnover related genes. Results are presented as
fold changes relative to sham control. Color changes from red to yellow and blue represent decreases in gene expression. (C), Real-time PCR analysis
for mRNA of ALP, osteocalcin, Runx2and myosin 2, 4, 7 in bone with different diets and 3 weeks following OVX in female rats. Data are expressed as
mean 6 SEM (n=8 per group). Means with different letters differ significantly from each other at p,0.05, a,b,c. (D), Western analysis of myosin and
Runx2 in bone from four different diet groups after 3 weeks of OVX, membrane ponceau S staining for protein loading control. Eight to nine samples
in each group were randomly pooled into three samples per group are presented for microarray analyses.
doi:10.1371/journal.pone.0024486.g003
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rounder than SABG-negative cells from the OVX long term BB
diet rat serum-treated group, where the cells were smaller and
spindle-shaped (Figure 7A). The SABG positive cell not only
showed less expression of myosin and Runx2 relative to the SABG
negative cell, but the limited expression of Runx2 was specifically
confined to the nucleus (Figure 7A). These observations suggested
that myosin expression in osteogenic cell may play a role in
shuttling Runx2 from cytoplasm to nucleus and vice versa.
Myosin-dependent nuclear-cytoplasmic shuttling of Runx2 may be
particularly important for providing a mutual link between myosin
and signal transduction cascades that ultimately control transcrip-
tion of downstream targets in osteoblastic cells. An association
between myosin and Runx2 was observed using co-immuno-
precipitation, and serum from OVX control rats decreased
(p,0.05) this myosin and Runx2 complex (Figure 7B). Consis-
tently, knockdown of the myosin gene in ST2 cells resulted in
reduced expression of Runx2 mRNA, and less potential for cells to
differentiate into osteoblasts even in the presence of BB serum
(Figure 7C). Following treatment with shRNA to myosin, ST2 cells
expressed greater (p,0.05) SABG activity (Figure 7C2), indicating
increased senescence.
Discussion
By treating animals with BB-supplemented diets either for a
short term prior to puberty or long term continuously from
weaning through adulthood, we have discovered that bone loss in
adulthood resulting from sex-steroid deficiency (herein referred as
OVX-induced bone loss) could be prevented. Our results suggest
Figure 4. BB diet prevents OVX-induced acute bone loss and osteoblastic cell senescence. (A), Senescence associated beta-galactosidase
(SABG) activity analyses in total proteins isolated from bone with four different diet groups. Data are expressed as mean 6 SEM (n=8 per group).
Means with different letters differ significantly from each other at p,0.05, a,b,c. (B), Triple staining of immune-staining for myosin and Runx2 and
SABG activity staining in long bone sections from four different diet groups 3 weeks after OVX. Pictures are showing typical bone surface osteoblasts
from sagittal section under 20 x magnifications, Green stains for myosin, red stains for Runx2 and blue stains for SABG and DAPI staining for nucleus.
doi:10.1371/journal.pone.0024486.g004
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its ability to increase cytoskeletal organization of osteoblastic cells,
which allows cells to maintain their appropriate differentiation
potential and function and which makes them resistant to
senescence.
We have presented results supporting a novel mechanistic
paradigm of how OVX-induced bone loss proceeds and how
dietary BB stimulates bone formation through enhancing myosin
expression in osteoblasts and their precursors. Our findings
indicate that organization of an appropriate cytoskeletal structure
may drive stem cells to differentiate into a functional and tissue-
specific mature cell. In particular, motor proteins in non-muscle
cells, such as myosin described in this report, may act as a shuttle
between cytoplasm and nucleus for essential osteoblastic cell
differentiation factors such as Runx2 (the runt domain-containing
transcription factor). The presence of this shuttle in osteoblastic
cell precursors in early life is particularly important to preserve the
fidelity of stromal cells for their differentiation potential later in
development. We have demonstrated Runx2 is a critical
mechanistic factor linking dietary BB, expression of cytoskeletal
proteins and lineage-specific cell fate, proliferation and growth.
Interestingly, our data suggest that OVX-induced degradation of
bone matrix may secondarily effect osteoblastic cell differentiation
and function through down-regulation of myosin expression
leading to a second phase of bone loss after OVX. This extended
effect has not previously been documented, and suggests a novel
Figure 5. Serum from BB diet intact animals stimulates osteoblast commitment and differentiation. (A), Regular RT-PCR analysis for
expressions of myosin1, 2, 3, 4, 6 and 7 in both calvarial osteogenic cells and ST2 cells. (B), Real-time PCR analysis for mRNA expression in mouse
origin bone marrow stromal ST2 cells after cells were treated with 2% BB diet animal serum for 3d. (C), Real-time PCR analysis for ALP mRNA
expression in mouse origin bone marrow stromal ST2 cells after cells treated with 2% BB diet animal serum for 3d, and then switched to regular cell
culture medium for an additional 4d. (D), Real-time PCR analysis for ALP mRNA expression in mouse origin bone marrow stromal ST2 cells after cells
treated with 2% BB diet animal serum, blebistatin 20 mm and their combination for 3d. Data are expressed as mean 6 SEM (triplicates). Means with
different letters differ significantly from each other at p,0.05, a,b,c.
doi:10.1371/journal.pone.0024486.g005
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which may involve metabolic programming, perhaps through
epigenetic modulation.
Theoretically, the lower the peak bone mass acquired by the
menopause, the higher the risk of osteoporosis later in life and the
earlier it begins. Accordingly, with all other factors being
approximately equal (such as, general health and age at
menopause), women with significantly greater peak bone mass at
menopause would be expected reach osteoporotic bone conditions
later in life. The age at which bone is acquired and the diet are two
critical factors thought to be important in determining peak bone
mass. For example, it is known that bone formation during
childhood and adolescence is very critical, and nearly half of the
peak bone mass is acquired during these years [16], [17]. Aside
from known dietary components required for bone development
and health (such as, adequate protein, calories, calcium,
phosphorus, and vitamin D), certain other dietary factors such
as phytochemicals may increase bone development and bone mass
which ultimately reduce the risk or degree of osteoporotic bone
loss later in life. We have previously reported that weaning rats
with only 2 weeks of BB supplemented diet had remarkable
increases in bone density and bone mineral content without
affecting normal growth and there were no gender differences [7].
It was concluded that dietary BB had a positive effect on building
peak bone mass. The significance of such increased peak bone
mass in early life by BB for buffering bone loss in an adult model of
estrogen deficiency (ovariectomy) is the topic of this report.
Bone loss occurs with increasing age in females is directly linked
to loss of ovarian function [18]. The pathophysiology of this
‘‘ovary-related’’ bone loss is very complicated and cannot be
simply explained by either increased bone resorption or decreased
bone formation [19]. Currently, treatment of postmenopausal
osteoporosis has been with drugs and hormone therapy, but some
of the approved treatments have specific negative side effects such
as mastalgia and increased risks of breast cancer and endometrial
hyperplasia. Furthermore, none of these treatments has been able
Figure 6. BB diet is able to maintain osteoblastic cell shape and prevent OVX-induced cell senescence. (A), After calvarial cells treated
one time with 2% of PBS (control), serum from three weeks of sham operated, OVX and long term BB plus OVX (BB OVX) rats for 3d, cell cultures were
switched to a regular medium until to last passage 9. Proteins were isolated from passage 9 cells, and senescence associated beta-galactosidase
activity was measured. (B), Passage 9 cells were stained with senescence associated beta-galactosidase activity; cells with blue color are positively
stained cells. (C), RNA were isolated from passage 9 cells, and mRNA expressions of ALP, Runx2 and myosin2, 4 were carried out by real-time PCR. (D),
Western analysis of myosin and Runx2 expressions in passage 9 cells. (E), Myosin and Runx2 double immune-staining was performed on passage 9
cells, myosin stained green and Runx2 stained red (10x). Data are expressed as mean 6 SEM (triplicates). Means with different letters differ
significantly from each other at p,0.05, a,b,c,d.
doi:10.1371/journal.pone.0024486.g006
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presented in the current study suggest that early life nutrition may
promote higher bone mass/quality which is maintained into
adulthood and protects against sex-steroid deficiency-induced
bone loss: a condition modeling postmenopausal bone loss in
women. Consistent with our findings, previous clinical and animal
studies have also demonstrated that increased bone mass in early
life produced by either appropriate nutrition or exercise persist
into early adulthood [20], [21], [22]. A recent rodent study
showing that neonatal mice treated with soy isoflavones produced
significant increases in adult bone quality [23]. Although the
underlying mechanisms still need to be defined, the above cited
studies are consistent with our findings.
Moreover, our findings indicate that bone marrow mesenchy-
mal stromal cells can be programmed postnatally by a dietary
factor to commit and differentiate into functional osteoblasts in
later adult life. In adults, appropriate bone remodeling is a
fundamental process in which new bone formation is tightly
associated with bone resorption to support and preserve skeletal
health. Ovarian dysfunction results in increases in bone resorption
which trigger transient compensatory increases in bone formation
to maintain bone remodeling at a set level. However, bone
formation is eventually exceeded by increased bone resorption, a
net bone loss results. The effects of dietary BB on osteoblastogen-
esis and osteoclastogenesis appear similar to that of estrogens.
However, the serum estrogen levels did not differ between BB-fed
rats and control rats. Therefore, it is unlikely that the effect of BB
diet on bone in OVX animals is due to increased levels of estrogen
or its related compounds.
One therapeutic approach has used agents with anabolic
properties to increase bone formation such as PTH (parathyroid
hormone) to treat ovary dysfunction-induced bone loss. Similar
bioactive compounds in serum associated with consumption of a
BB-containing diet are still under investigation in our laboratory.
Dietary BB-induced serum phenolic acids [7] may play a key role
in protecting against OVX-induced bone loss by stimulating bone
Figure 7. Myosin and Runx2 interaction determines osteoblastic cell senescence. (A), A single morphologically normal and senescence
associated beta-galactosidase (SABG) negative osteoblastic cell was compared with a SABG positive cell from OVX rat serum treated on myosin and
Runx2 expression and localization. Myosin stained green and Runx2 stained red with antibody immune staining. (B), Coimmunoprecipitation of
myosin and Runx2 in lysates of calvarial cells cultured and treated with 2% of sham operated, OVX and continuous BB diet plus OVX (BB OVX) rat
serum. (C1), Myosin and Runx2 mRNA expressions after silencing of the myosin gene using shRNA myosin in ST2 cells. Data are expressed as mean 6
SEM (triplicates). *, p,0.05, significantly different than control non shRNA normal culture medium. (C2), SABG activity in ST2 cells with or without
shRNA myosin. Data are expressed as mean 6 SEM (triplicates). *, p,0.05, significantly different than control. (C3), Regular PCR to check myosin
expression after shRNA in ST2 cells. (C4), Runx2 immuno-staining (stained red) after shRNA myosin in ST2 cells.
doi:10.1371/journal.pone.0024486.g007
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prevent bone and osteoblastic cells from acutely entering
senescence after OVX is an interesting and novel finding. Previous
studies have suggested that osteoblast apoptosis was increased in
addition to increased osteoclast activity after OVX in female
rodents [18]. It is not known whether osteoblast apoptosis is an
important consequence of increased bone remodeling after OVX.
We believe that the rapid entry into cell senescence may be an
important fate of osteoblasts after OVX. As we have demonstrated
in this report, the activity of senescent osteoblasts was significantly
lower, and their cell shape may be changed, but they can still
identified as osteoblasts. This is consistent with our histomorpho-
metric observation which showed increased osteoblast numbers in
OVX animals particularly after 1 week. BB diet may increase the
life span of osteoblastic stromal stem cells and progenitor self
renewal, and may also enhance osteoblast commitment and
differentiation. Determining the mechanisms whereby blueberries
prevent the OVX-induced osteoblast senescence requires further
elucidation. Furthermore, the mechanisms by which OVX triggers
osteoblasts to rapidly enter senescence may be fundamental for
understanding the true pathophysiology of OVX-induced bone
loss.
Microarray data analyses revealed a cluster of myofibril gene
expression particularly myosin related genes that were remarkably
down-regulated after OVX in total RNA isolated from bone.
Dietary BB significantly inhibited OVX-induced suppression of
myosin expression in bone. Furthermore the expression of myosin,
particularly non-cardiovascular myosin, is broad and the spectra of
their functions have not been fully described in non muscular
tissue. We believe that myosin not only plays a role in supporting
cell structure, but also conveys some molecular signals in cells from
non muscular tissue, and bone forming osteoblasts or their
precursors are unlikely to be an exception. We have shown that at
least 6 myosin subtypes are highly expressed in osteogenic cells and
osteoblastic stromal cells. Reduction of myosin expression in
skeletal muscle after OVX has been reported [24], and
interestingly, during osteoclastogenesis, myosin IIA may be
temporarily suppressed [25]. Moreover, recent studies have
suggested that myosin may play a role in driving a cell to remodel,
and eventually influence stromal cells to differentiate into tissue-
specific cells [26]. We have found evidence that myosin expression
in osteogenic cells and mesenchymal stromal cells may be
associated with maintaining Runx2 expression and shuttling this
well known essential osteoblast differentiation transcription factor
between cell cytoplasm and nucleus. Runx2 has been shown to
establish and maintain cell identity and convey phenotypic
information through successive cell division or exit in progeny
cells [27], and it is required for osteoblast differentiation [28]. The
phenomenon of Runx2 shuttling between the cytoplasm and the
nucleus has been reported and may depend on microtubules in
cancer cells [29]. Our data in osteogenic cells indicated an
association of myosin with Runx2. Treatment of osteogenic cells
with serum from OVX control diet rats decreased both myosin
and Runx2 complex, but treatment with serum from BB-fed rats
increased this complex. To maintain this complex at the
appropriate functional level may be particularly important,
because significantly reduced expression of Runx2 level will not
only suppress osteoblast differentiation, but also result in a cell
entering the senescent stage. This is consistent with previous
published evidence showing that Runx2 interacts with histone
deacetylase 6 to repress the p21 gene, known as a downstream
effecter of p53 that is associated with cell senescence [30]
Moreover, it has been shown that myosin VI DNA damage is
p53-dependent [31]. Consuming BB early in life contributes to
development or maintenance of the myosin-dependent Runx2
shuttle, and this may also be important to preserve the ability of
mesenchymal stromal cells to differentiate into functional
osteoblasts later in life under inappropriate stress. However, the
mechanistic associations among specific subtypes of myosin,
Runx2 and p53 in osteoblastic cells need to be further elucidated.
In conclusion, we have reported that ovariectomy triggers acute
bone loss and osteoblastic cell senescence in association with
decreased expression of myofibril genes. Consuming a BB diet for
just a short period in prepubertal life or continuous consumption
starting a weaning both prevented OVX-induced bone loss and
osteoblastic cell senescence in adult female rats. We have
demonstrated that early exposure of osteoblastic cells or
mesenchymal stromal cells to dietary BB maintains long-term
cytoskeletal stability by regulation of myosin and Runx2 genes.
These results show a significant prevention of OVX-induced bone
loss by early life dietary BB, and further provide insight into
molecular events of mesenchymal stromal cell senescence and
osteoblast differentiation associated with OVX.
Materials and Methods
Animals and Diets
Time-impregnated female Sprague-Dawley rats (n=6) (Harlan
Industries, Indianapolis, IN) gestational day 4 were individually
housed in an Association for Assessment and Accreditation of
Laboratory Animal Care-approved animal facility at the Arkansas
Children’s Hospital Research Institute with constant humidity and
lights on from 06:00-18:00 hrs at 22uC. All animal procedures
were approved by the Institutional Animal Care and Use
Committee at University of Arkansas for Medical Sciences
(UAMS). The approval ID for this study is 2473. Pregnant rats
were fed AIN-93G diets [32]. Litters from these dams were culled
to 5 male and 5 female pups. Pups at post-natal day 20 (PND20)
were randomly assigned (10 per group) to AIN-93G diets with or
without blueberry (BB) supplementation until PND34 as the short-
term BB group, and BB diet from PND20 throughout life as the
long-term BB group. Each group of animals and their detailed
diets, surgery and age are presented in Supplemental Figure 1.
Freeze-dried whole BB (Vaccinium angustifolium) powder (Hi-
Actives Wild Blueberry) was kindly provided by VDF/Future-
Ceuticals, Momence, IL. AIN-93G supplemented with 10%
freeze-dried BB powder (10%BB) was made by Harlan Teklad
(Madison, WI). To eliminate caloric density as a confounding
variable, all diets were formulated to be isocaloric and isonitro-
genous. The diets contained the National Research Council
nutrient recommendations and the same calcium and phosphorus
levels [33]. Animals were weighed every other day.
Bone peripheral quantitative computerized tomography
(pQCT) and histomorphometry
At sacrifice the right rear tibia was removed and frozen in liquid
nitrogen. pQCT scans were performed on individual tibial bones
from each rat using a STRATEC XCT 960M unit (XCT
Research SA, Norland Medical Systems, Fort Atkins, WI) with
software version 5.4. The detail of pQCT scanning was described
previously [34]. Several key points were briefly summarized below.
The position for pQCT scanning was defined at a distance from
the proximal tibia growth plate. All analyses were conducted in a
blinded fashion. Five consecutive slices separated by 1 mm (1
through 5, 1 being most distal) were scanned for each tibia
beginning immediately below the tibial growth plate. Data from
slice 2 and 3 were combined and presented in Figure 1. A
threshold of 470 mg/cm
3 was used to distinguish cortical bone,
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3 was used to distinguish cancellous bone through
the experiment. Tibial bone mineral density (BMD) was separated
into total and trabecular and cortical compartments and bone
mineral content (BMC) were automatically calculated and color
images were generated. At sacrifice, calcein-labeled, left rear tibial
bones were removed and fixed, sequential dehydration was carried
out using different concentrations of alcohol. Proximal tibial bone
samples were embedded, cut and von Kossa, tetrachrome and
Masson stained by Histology Special Procedures. For histomor-
phometric analysis, sections were read in a blinded fashion.
Parameters of cancellous and cortical bones in the proximal tibia
and tibial shaft were measured with a digitizing morphometry
system, which consists of an epifluorescent microscope (model BH-
2, Olympus), a color video camera, and a digitizing pad
(Numonics 2206) coupled to a computer (Sony) and a morphom-
etry program OsteoMetrics (OsteoMetrics, Inc.). Total bone area,
total bone surface, osteoid surface, osteoblast surface, osteoclast
surface, eroded surface, osteoid area, and single- and double-
labeled perimeters were obtained by manual tracing.
Measurement of serum bone turnover markers
The serum bone formation markers bone-specific alkaline
phosphatase (ALP), osteocalcin and IGF1 were measured using
enzyme immunoassay kits from Quidel Corporation (San Diego,
CA). Based on data provided by manufacture, intra- and inter-
assay coefficients and sensitivity of the assay are 5.3%, 7.3% and
0.78 U/L for ALP, 5.0%, 5.5% and 50.0 ng/mL for osteocalcin,
4.3%, 8.3% and 0.026 ng/ml for IGF1, respectively. The serum
bone resorption marker RatLaps ELISA kit was purchased from
Nordic Bioscience Diagnostics A/S (Herlev, Denmark). According
to the manufacturer’s recommendation, 50 ml of serum from each
sample was used and the absorbance at 450 nm with subtraction
at 650 nm was measured. Intra- and inter-assay coefficients and
sensitivity of the assay are 5.6%, 10.5% and 2.0 ng/mL.
Microarray and Real-Time Reverse Transcription-
Polymerase Chain Reaction
Right tibial bone total RNA and in vitro cultured cell RNA were
extracted using TRI Reagent (MRC Inc., Cincinnati, OH)
according to the manufacturer’s recommendations followed by
DNasedigestionandcolumncleanupusingQIAGENminicolumns.
Three microarrays(GeneChipRat 2302.0;Affymetrix,Santa Clara,
CA) were used for each group either samples from in vivo or in vitro.
Pools of equal amounts of RNA from two to three rats were used for
analyses per microarray, representing at least eight rats per group
over the three microarrays. cRNA synthesis, labeling, hybridization,
and scanning were carried out using the manufacturer’s instructions
and described previously in our lab [35]. Microarray data analyses
were carried out using GeneSpring version 7.3X software (Agilent
Technologies, Santa Clara, CA) [35]. The CEL files containing
probe level intensities were processed using the robust multiarray
analysis algorithm for background adjustment, normalization, and
log2 transformation of perfect match values [35]. Subsequently, the
data were subjected to normalization by setting measurements less
than 0.01 to 0.01 and by per-chip and per-gene normalization using
GeneSpring. The normalized data were used to generate a list of
differentially expressed genes among different diets with and without
BB. Reverse transcription was carried out using an iScript cDNA
synthesis kit from Bio-Rad (Hercules, CA). Real-time RT-PCR was
carried out using SYBR Green and an ABI 7000 sequence detection
system (Applied Biosystems, Foster City, CA). Primers for all genes
usedinthisreportweredesignedusingPrimerExpresssoftware2.0.0
(Applied Biosystems) and listed in a Table S1. All data is MIAME
compliant and that the raw data has been deposited in a MIAME
compliant database (E.g. ArrayExpress, GEO), as detailed on
the MGED Society website http://www.mged.org/Workgroups/
MIAME/miame.html with GSE30081.
In vitro cell cultures and osteoblast differentiation assay
Neonatal rat calvarial osteoblastic cells were isolated from control
rat 4 days old pups by sequential collagenase digestion using a
method described previously [36]. Rat fetal calvarial osteoblastic
cells and the mouse origin bone marrow mesenchymal stromal cell
line ST2 were cultured in a-MEM supplemented with 10% FBS.
Cells were seeded in six-well cell culture plates at a density of
1.5610
6 cells per well. Cell cultures were maintained in the
presence of minimal essential medium (Invitrogen, Calsbad, CA)
with 15% fetal bovine serum (FBS) (Hyclone Laboratories, Logan,
UT) and 1 mM ascorbyl-2-phosphate (Sigma-Aldrich, St. Louis,
MO), 4 Mm L-glutamine, and 100 U/ml each of penicillin and
streptomycin (Sigma-Aldrich) as osteogenic medium. Cell cultures
were stopped at indicated time points and were fixed and stained
with alkaline phosphatase (ALP) and RNA and protein assays.
Senescence-associated beta-galactosidase activity and
staining
Senescence-associated beta-galactosidase activity assay was
performed by beta-galactosidase enzyme assay kit (Promega)
measured the absorbance at 420 nm according to manufacture’s
instruction. Bone section and cell beta-galactosidase staining were
also performed according to a method published previously [36]
Senescent cells were identified as blue-stained cells by standard
light microscopy.
Transient transfection and shRNA
ShRNA myosin (sc-149741-SH) was purchased from Santa
Cruz (Santa Cruz BioTechnology, Inc, www.scbt.com), and
transfection of shRNA myosin into ST2 cells were carried out
using Amaxa cell line nucleofector kit (Amaxa Biosystems, www.
lonza.com).
Western blotting and immunoprecipitation
Right tibial bone tissue proteins for Western immunoblot
analysis were extracted using cell lysis buffer as described
previously [36]. Western blot and immunoprecipitation analyses
were performed using standard protocols. Primary and secondary
antibodies for myosin, beta-actin, Runx2, were purchased from
Santa Cruz Biotechnology and Cell Signaling. Blots were
developed using chemiluminescence (PIERCE Biotechnology)
according to the manufacture’s recommendations. Quantification
of the intensity of the bands in the autoradiograms was performed
using a VersaDoc
TM imaging system (Bio-Rad).
Data and statistical analyses
Data were expressed as means 6 SEM. One way analysis of
variance (ANOVA) was utilized followed by student Newman-
Keuls post hoc analyses for multiple pair-wise comparisons
between treatment groups. Values were considered statistically
significant at p,0.05.
Supporting Information
Figure S1 Experimental design. (A), Diagramed experimen-
tal design, including age, diet duration, diet switch and
ovariectomy surgery time. (B). Body weight information. Exper-
imental animals were weighed every other day.
(TIF)
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sin and Runx2 and SABG activity staining in long bone
sections from four different diet groups 3 weeks after
OVX. Pictures are showing typical bone surface area from sagittal
section under 10 x magnifications, Green stains for myosin, red
stains for Runx2 and blue stains for SABG and DAPI staining for
nucleus. White arrows indicate a osteoblastic cell on bone surface.
OVX, Ovariectomy; Sham, Sham operated. LTBB OVX, long
term blueberry supplemented diet throughout experiment and
ovariectomy. STBB OVX, short term blueberry diet for 14 days
from weaning postnatal date 20 to PND 34, then switch to control
diet and ovariectomy.
(TIF)
Figure S3 Real-time PCR analysis for Myh2, 4, 7
(myosin 2, 4, 7) and ALP mRNA expression in isolated
control neonatal rat calvarial cells after cells were
treated with control vehicle, 2% diet animal serum
from casein control (Cas) and blueberry (BB) for 24 h
and 48 h. Data are expressed as mean 6 SEM (triplicates).
Means with different letters differ significantly from each other at
p,0.05, a,b,c.
(TIF)
Figure S4 Original housekeeping gene normalized mi-
croarray data. 1.5 fold up- or down-regulated genes are
presented.
(TIF)
Figure S5 Serum from BB diet animals prevents OVX-
induced osteoblastic cell senescence. (A), After ST2 cells
treated one time with 2% of PBS (control), serum from three weeks
of sham operated (Sham), OVX and long term BB plus OVX (BB-
OVX) rats for 3d, cell cultures were switched to a regular medium
until to last passage 9 (p9). Total cell numbers were counted at
each passage time. (B), Proteins were isolated from passage 9 cells,
and senescence associated beta-galactosidase activity was mea-
sured. (C), RNA were isolated from passage 9 cells, and mRNA
expressions of ALP, Runx2 and myosin4, 7 (Myh4,7) were carried
out by real-time PCR.
(TIF)
Figure S6 In vitro cell culture model. (A), in vitro cell culture
experimental design. (B), After calvarial cells treated one time with
2% of PBS (control), serum from three weeks of sham operated
(Sham), OVX and long term BB plus OVX (BB-OVX) rats for 3d,
cell cultures were switched to a regular medium until to last
passage 9 (p9). Total cell numbers were counted at each passage
time.
(TIF)
Table S1 Real-time PCR primer sequences.
(DOC)
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